Related Experiment Video
Updated: Apr 16, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Does 18F-FDG PET/MRI reduce the number of indeterminate abdominal incidentalomas compared with 18F-FDG PET/CT?
Benedikt M Schaarschmidt1, Johannes Grueneisen, Philipp Heusch
1aDepartment of Diagnostic and Interventional Radiology, Medical Faculty, University of Dusseldorf, Dusseldorf bDepartment of Diagnostic and Interventional Radiology and Neuroradiology cDepartment of Nuclear Medicine, Medical Faculty, University of Duisburg-Essen, Essen, Germany.
Objective:
Incidental masses of abdominal organs are a relevant problem in radiological examinations. The aim of this study was to evaluate whether simultaneous (18)F-fluorodeoxyglucose ((18)F-FDG) PET/MRI, because of its higher soft-tissue contrast and the diversity of available pulse sequences, can reduce the number of indeterminate abdominal incidentalomas compared with (18)F-FDG PET/computed tomography (CT).
Materials And Methods:
In this retrospective study, we enrolled 173 patients (91 women and 82 men, mean age 55.8±14.6 years) who underwent contrast-enhanced (18)F-FDG PET/CT on the same day for oncological indications. Data sets were examined in a random order by two readers noting incidentalomas and incidental tracer uptake of the liver, kidneys, spleen, pancreas, adrenal glands, and gallbladder. Findings were categorized into three categories: most likely malignant, indeterminate, and most likely benign. In addition, the most relevant MR sequence for the final decision was recorded for each incidentaloma. The numbers of benign, indeterminate, and malignant findings on (18)F-FDG PET/CT and (18)F-FDG PET/MRI were compared. A subgroup analysis was carried out to detect potential differences with respect to lesion location (organwise) and lesion consistency (solid vs. cystic).
Results:
A total of 649 upper abdominal incidentalomas were found. (18)F-FDG PET/MRI detected more incidentalomas (n=635) than contrast-enhanced (18)F-FDG PET/CT (n=407, P<0.001). Using (18)F-FDG PET/MRI, significantly fewer incidentalomas were categorized as indeterminate compared with (18)F-FDG PET/CT (n=27 vs. 91, P<0.001). This was true for cystic (P<0.001) as well as solid masses (P<0.001). Seventy incidentalomas categorized as indeterminate on contrast-enhanced (18)F-FDG PET/CT could be clarified as most likely benign by (18)F-FDG PET/MRI, whereas only six lesions rated as benign by (18)F-FDG PET/CT were classified as indeterminate in (18)F-FDG PET/MRI. (18)F-FDG PET/MRI compared with contrast-enhanced (18)F-FDG PET/CT had significantly fewer indeterminate findings in the liver (P<0.001), kidneys (P=0.012), and adrenal glands (P=0.002); differences for the spleen (P=0.5) were not significant.
Conclusion:
(18)F-FDG PET/MRI identifies more incidentalomas than (18)F-FDG PET/CT, but significantly reduces the number of indeterminate incidental findings of abdominal organs.
Insights
(18)F-fluorodeoxyglucose (FDG) PET/MRI detects more abdominal incidentalomas than PET/CT. This advanced imaging technique significantly reduces indeterminate findings, improving diagnostic clarity for abdominal incidentalomas.
Area of Science:
- Radiology
- Nuclear Medicine
- Oncology
Background:
- Incidentalomas in abdominal organs are frequently discovered during radiological examinations.
- Distinguishing benign from malignant incidentalomas can be challenging with conventional imaging.
Purpose of the Study:
- To compare the efficacy of simultaneous (18)F-fluorodeoxyglucose ((18)F-FDG) PET/MRI versus (18)F-FDG PET/CT in reducing indeterminate abdominal incidentalomas.
- To leverage the superior soft-tissue contrast and diverse sequences of PET/MRI for improved characterization.
Main Methods:
- Retrospective analysis of 173 patients who underwent contrast-enhanced (18)F-FDG PET/CT.
- Two readers evaluated PET/CT and PET/MRI datasets for incidentalomas in abdominal organs.
- Findings were classified as most likely malignant, indeterminate, or most likely benign.
Main Results:
- (18)F-FDG PET/MRI identified more incidentalomas (n=635) compared to PET/CT (n=407).
- Significantly fewer indeterminate findings were observed with PET/MRI (n=27) versus PET/CT (n=91).
- PET/MRI clarified 70 indeterminate lesions from PET/CT as likely benign.
Conclusions:
- Simultaneous (18)F-FDG PET/MRI is superior to PET/CT in detecting abdominal incidentalomas.
- (18)F-FDG PET/MRI significantly decreases the proportion of indeterminate findings, enhancing diagnostic confidence.
More Related Videos
10:02Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography FDG-PET/CT
Published on: May 2, 2012
10:02Whole-body PET/MRI of Pediatric Patients: The Details That Matter
Published on: December 19, 2017
Related Concept Videos
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Imaging Studies III: Computed Tomography
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...